Loop Capital initiated coverage on WEX with a new price target
Loop Capital initiated coverage of WEX with a rating of Buy and set a new price target of $195.00
- BNP Paribas Exane initiated coverage on Versigent with a new price target
BNP Paribas Exane initiated coverage of Versigent with a rating of Outperform and set a new price target of $41.00
- Guggenheim initiated coverage on Satellos Bioscience with a new price target
Guggenheim initiated coverage of Satellos Bioscience with a rating of Buy and set a new price target of $23.00
- Citizens initiated coverage on Opus Genetics with a new price target
Citizens initiated coverage of Opus Genetics with a rating of Mkt Perform and set a new price target of $12.00
- DA Davidson initiated coverage on Micron with a new price target
DA Davidson initiated coverage of Micron with a rating of Buy and set a new price target of $1,000.00
- William Blair initiated coverage on McKesson
William Blair initiated coverage of McKesson with a rating of Outperform
- Commvault Announces Fourth Quarter Fiscal 2026 Financial Results
Achieved all fourth quarter and fiscal 2026 guided metricsRecord $132 million free cash flow in fourth quarterTotal reported ARR grew +21% year over year, with $44 million in constant currency net new ARRTinton Falls, N.J., April 28, 2026 /PRNewswire/ -- Commvault (NASDAQ:CVLT) today announced its financial results for the fourth quarter and fiscal year ended March 31, 2026. "Our results reinforce that we are delivering durable growth fueled through industry-leading innovation and our rapidly expanding SaaS business," said Sanjay Mirchandani, President and CEO, Commvault. "In fi
- Compass Point initiated coverage on Invitation Homes with a new price target
Compass Point initiated coverage of Invitation Homes with a rating of Neutral and set a new price target of $30.00
- TD Cowen initiated coverage on Immatics N.V.
TD Cowen initiated coverage of Immatics N.V. with a rating of Buy
- Marsh and Formula 1® Announce Official Multi-Year Partnership
A strategic partnership that aligns with Marsh's global expertise in risk, reinsurance and consulting Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments and management consulting, today announced a multi-year partnership with the global sport of Formula 1® as the series' first Official Risk Partner and Official Insurance Brokering Partner, marking a bold step as a unified, global brand. Anchored in Marsh's purpose—building the confidence to thrive through the power of perspective—the partnership reinforces a shared commitment to performance, innovation, and global impact. This press release features multimedia. View the full release here: https://
- Barclays initiated coverage on Fortis with a new price target
Barclays initiated coverage of Fortis with a rating of Overweight and set a new price target of $62.00
- Raymond James resumed coverage on Enterprises Finl with a new price target
Raymond James resumed coverage of Enterprises Finl with a rating of Outperform and set a new price target of $65.00
- H.C. Wainwright initiated coverage on First Tracks Biotherapeutics with a new price target
H.C. Wainwright initiated coverage of First Tracks Biotherapeutics with a rating of Buy and set a new price target of $30.00
- Barclays initiated coverage on Emera with a new price target
Barclays initiated coverage of Emera with a rating of Equal Weight and set a new price target of $53.00
- William Blair initiated coverage on Cencora
William Blair initiated coverage of Cencora with a rating of Mkt Perform
- William Blair initiated coverage on Cardinal Health
William Blair initiated coverage of Cardinal Health with a rating of Outperform
- Compass Point initiated coverage on American Homes 4 Rent with a new price target
Compass Point initiated coverage of American Homes 4 Rent with a rating of Buy and set a new price target of $37.50
- Tronox downgraded by Truist with a new price target
Truist downgraded Tronox from Hold to Sell and set a new price target of $8.00
- Rambus downgraded by Robert W. Baird with a new price target
Robert W. Baird downgraded Rambus from Outperform to Neutral and set a new price target of $120.00
- Nucor downgraded by UBS with a new price target
UBS downgraded Nucor from Buy to Neutral and set a new price target of $224.00